Efficacy and Tolerability of Full Dose Enteric-coated Mycophenolate Sodium, in Addition to Cyclosporine for Microemulsion Reduced Dose, in Maintenance Renal Transplant Recipients

NCT00434590 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

10

Enrollment

INDUSTRY

Sponsor class

Stopped The study has been stopped because of the lack of enrollment

Conditions

Kidney Transplantation

Interventions

DRUG: Enteric coated mycophenolate sodium (Myfortic®)

Sponsor

Novartis Pharmaceuticals